基本信息
浏览量:14
职业迁徙
个人简介
Recent research interest of Professor De Smedt have included micro- and nanomaterials for (especially) drug delivery and diagnostics. His research is at the interface between drug delivery, biophysics, material sciences and advanced optical imaging. Dr. Stefaan De Smedt holds patents on carriers for drug delivery and diagnostics. He is a scientific founder of Memobead Technologies, a spin-off from Ghent University, whose technology is currently under further development by Biocartis in Lausanne (Swiss) and Mechelen (Belgium). Dr. De Smedt is a member of the Drug Delivery Advisory Panel of Santen Pharmaceutical specialized in ophthalmic pharmaceuticals.
研究兴趣
论文共 545 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Advanced drug delivery reviews (2024): 115215-115215
Journal of controlled release : official journal of the Controlled Release Society (2024): iii-iv
BIOENGINEERING & TRANSLATIONAL MEDICINE (2024)
CHEMICAL SOCIETY REVIEWSno. 1 (2024): 317-360
Bram Bogaert, Aliona Debisschop, Thomas Ehouarne,Hannelore P. Van Eeckhoutte,Joyceline De Volder,An Jacobs,Eline Pottie,Riet De Rycke,Aurelie Crabbe,Pieter Mestdagh,Ine Lentacker,Guy G. Brusselle,
Trends in cancer (2024)
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (2024): 114223-114223
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2024)
Sofie Meulewaeter,Ilke Aernout,Joke Deprez, Yanou Engelen, Margo De Velder,Lorenzo Franceschini,Karine Breckpot,Serge Van Calenbergh,Caroline Asselman,Katie Boucher,Francis Impens,Stefaan C De Smedt,
Journal of controlled release : official journal of the Controlled Release Society (2024): 379-391
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn